The Cooper Companies, Inc. (NYSE:COO) reported Q3 results, with EPS of $3.41, which beat the consensus estimate of $3.30. Quarterly revenue came in at $763.4 million, 5.36% better than the Street estimate.

For the full 2021-year, the company expects total revenue to range from $2.89 billion to $2.92 billion, above the consensus estimate of $2.87 billion.

The company saw 16% growth in the Americas region seeing a continued improvement in patient flow, EMEA (growing 24%) captured market share and saw consumer activity return, and APAC (growing 18%) consumer activity remain somewhat muted, though continues to rebound led by steady improvements.

Analysts at Oppenheimer raised their price target on the company to $475 from $405. While competition in the contact lens market remains stiff, the brokerage estimates above-market contact lens growth for the company driven by its specialty lens offerings and by increased silicone hydrogel daily penetration.